Literature DB >> 19719776

GPCR theme editorial.

G Milligan, J C McGrath.   

Abstract

This themed section of BJP includes 11 reviews on the biology of G-protein coupled receptors (GPCRs) and the drug targets that these present, 21 research papers on the pharmacology of a range of GPCRs and Commentaries on four of the papers. Areas reviewed include molecular interactions, particular in respect of hetero-dimerisation between receptors and other membrane-located proteins and other key signalling molecules including cAMP and G12/13 proteins and recently de-orphanised receptors including the Neuromedins U & S and the Free Fatty Acid receptors FFA2 & FFA3. The research papers cover the pharmacology of a range of agents acting at GPCRs, including adrenoceptors, purinoceptors, 5HT, opioid, cannabinoid & PAR-2 receptors. A group of papers is concerned with the interesting and rapidly developing pharmacology of drugs acting at beta(2)-adrenoceptors. The reach of GPCRs is illustrated by the range of physiological systems and therapeutic applications involved, including pain, cancer, cardiovascular, gastrointestinal, visual and respiratory and central nervous systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719776      PMCID: PMC2795254          DOI: 10.1111/j.1476-5381.2009.00422.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  70 in total

Review 1.  Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.

Authors:  P G Strange
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

Review 2.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 3.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

Review 4.  Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system.

Authors:  X Rovira; M Vivó; J Serra; D Roche; P G Strange; J Giraldo
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

Review 5.  The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.

Authors:  E Davis; R Loiacono; R J Summers
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

6.  The signal transduction cascade regulating the expression of the gap junction protein connexin43 by beta-adrenoceptors.

Authors:  A Salameh; S Krautblatter; S Karl; K Blanke; D Rojas Gomez; S Dhein; D Pfeiffer; J Janousek
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

Review 7.  Role of protein kinase C in functional selectivity for desensitization at the mu-opioid receptor: from pharmacological curiosity to therapeutic potential.

Authors:  Susan L Ingram; John R Traynor
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

Review 8.  Stimulation of cardiac beta-adrenoceptors targets connexin 43.

Authors:  Kerstin Boengler
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

9.  The alpha1L-adrenoceptor is an alternative phenotype of the alpha1A-adrenoceptor.

Authors:  Cp Nelson
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

Review 10.  cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies.

Authors:  Manuela Zaccolo
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

View more
  2 in total

1.  Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.

Authors:  Chantevy Pou; Clotilde Mannoury la Cour; Leigh A Stoddart; Mark J Millan; Graeme Milligan
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

2.  2010 re-launch of BJP.

Authors:  J C McGrath
Journal:  Br J Pharmacol       Date:  2010-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.